Edwards Lifesciences Corp — Form 4
Filed October 8, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 46/100
What the filing says
CVP, TAVR Lippis Daniel J. (EW) sold 1K shares (~$53K) on the open market (29% of holdings). Large sale — ~29% of holdings.
Why this rating
Large sale — ~29% of holdings.
See more from October 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.